The city’s plaintiffs lawyers were in a mood Wednesday to become the first mass of humanity to dance down Broad Street since the Phillies won the World Series.
Their cause for jubilation: the U.S. Supreme Court’s much anticipated decision in Wyeth v. Levine . In a 6-3 decision, the high court affirmed lower courts’ rulings that state tort claims over the warning labels of pharmaceuticals could not be pre-empted by federal law simply because the U.S. Food and Drug Administration had approved the warning labels.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
